HIGHLIGHTS
- who: Judith van Dalem from the Sciences, Utrecht, the NetherlandsDepartment of Clinical Pharmacy, Maastricht University Medical Centre+, Maastricht, the Netherlands have published the research: Determinants of treatment modification before and after implementation of the updated 2015 NICE guideline on type 2 diabetes: A retrospective cohort study, in the Journal: (JOURNAL)
- what: The aim of this study was to identify patient-specific determinants of early treatment modification (addition of or switching to second-line therapy within one year) in patients with type 2 diabetes before and after implementation of the updated NICE guideline in the UK . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.